AQR Capital Management - IMMUNOMEDICS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$6,254,000
+30.7%
73,546
-45.5%
0.01%
+37.5%
Q2 2020$4,785,000
+1295.0%
135,027
+430.3%
0.01%
+700.0%
Q1 2020$343,000
-5.2%
25,460
+35.3%
0.00%
Q1 2019$362,000
-59.0%
18,819
-69.6%
0.00%
-100.0%
Q4 2018$884,000
-48.8%
61,953
-25.2%
0.00%
-50.0%
Q3 2018$1,725,000
-14.9%
82,795
-3.3%
0.00%0.0%
Q2 2018$2,026,000
+51.2%
85,595
-6.6%
0.00%
+100.0%
Q1 2018$1,340,000
-19.8%
91,685
-11.3%
0.00%
-50.0%
Q4 2017$1,670,000
+25.4%
103,332
+8.5%
0.00%0.0%
Q3 2017$1,332,000
+90.8%
95,265
+20.6%
0.00%
+100.0%
Q2 2017$698,000
+69.4%
79,015
+24.2%
0.00%0.0%
Q1 2017$412,000
+421.5%
63,626
+285.6%
0.00%
Q4 2014$79,000
-55.4%
16,500
-65.4%
0.00%
Q3 2014$177,000
-42.3%
47,700
-43.3%
0.00%
-100.0%
Q2 2014$307,000
-12.0%
84,200
+1.4%
0.00%0.0%
Q1 2014$349,000
+34.7%
83,000
+47.2%
0.00%0.0%
Q4 2013$259,000
-25.8%
56,4000.0%0.00%0.0%
Q3 2013$349,000
+106.5%
56,400
+81.9%
0.00%0.0%
Q2 2013$169,000
+85.7%
31,0000.0%0.00%
Q4 2012$91,00031,0000.00%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders